Piperidinesulfonylureas and -thioureas, their preparation, their use and pharmaceutical compositions comprising them

Details for Australian Patent Application No. 2005315927 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Gerlach, Uwe; Lehr, Karl-Heinz; Knieps, Stephanie; Goegelein, Heinz; Pfeiffer-Marek, Stefania; Heitsch, Holger; Englert, Heinrich Christian

Agent Watermark

Pub. Number AU-B-2005315927

PCT Pub. Number WO2006/063722

Priority 10 2004 061 017.7 18.12.04 DE

Filing date 7 December 2005

Wipo publication date 22 June 2006

Acceptance publication date 9 February 2012

International Classifications

C07D 211/96 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

Event Publications

12 July 2007 PCT application entered the National Phase

  PCT publication WO2006/063722 Priority application(s): WO2006/063722

9 February 2012 Application Accepted

  Published as AU-B-2005315927

7 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005315928-High-throughput Enzyme-linked Immuno absorbent Assay (HT-ELISA) for identifying R Rho-kinase (ROK) modulator

2005315923-Piperazinyl pyridine derivatives as antiobesity agents